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Effects of Normal Mouse Serum on the IL-3-Induced Proliferation of Bone
Marrow Cells
By Carol A. DahI and Christer Lindqvist
Normal mouse serum (NMS) devoid of colony-stimulating
factor (CSF) was found to enhance the interleukin 3
(11-3)-driven colony formation of bone marrow in vitro.
Inclusion of NMS in bone marrow colony-forming assays
resulted in greatly increased numbers of colonies and
clusters following seven days incubation; however. incuba-
tion of bone marrow with NMS before the colony-forming
assay had no effect on resultant colony number. The levels
of serum-enhancing activity (SEA) did not appear to vary
significantly with age and in part was species restricted, in
that human and guinea pig serum did not enhance mouse
bone marrow colony formation. Conversely. NMS had no
effect on human bone marrow colony formation. Levels of
SEA were found to vary between strains. as did the degree
A VARIETY OF FACTORS have been found to
influence the in vitro proliferation and colony forma-
tion of hemopoietic progenitor cells. Essential to the prolifer-
ation and differentiation of hemopoietic progenitors are
colony-stimulating factors, such as interleukin 3, which
selectively stimulate the formation of colonies of particular
committed progenitor cell types.’￿’ Additionally, there are
factors such as interferon and acidic isoferritins￿7 that can
reduce the colony formation of CSF-stimulated progenitors
(eg, colony-forming unit-granulocyte-macrophage [CFU-
GM]), and other factors such as hemin and hemoglobin that
enhance the colony formation by CSF-stimulated progenitor
cells.8’9 It has also been shown that certain interleukins
and/or CSFs can have synergistic effects on bone marrow
colony formation.’#{176}￿’4 We report here the presence of a
factor(s) in normal mouse serum which greatly enhances the
IL-3-stimulated in vitro colony formation of murine bone
marrow cells. This activity is present in sera containing no
detectable CSF and has no effects on cells during preincuba-
tion in the absence of IL-3, yet it greatly enhances colony
formation even when it is added late in the course of the
assay.
MATERIALS AND METHODS
Mice. Mice were obtained from Gl. Bomhabtgard, Ry, Den-
mark; Department of Immunology, University of Uppsala; Depart-
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to which bone marrow from various strains was enhanced
by the serum. Serum fractionation studies indicated three
active fractions with molecular weights of 800-900 Kd,
60-70 Kd. and 20-30 Kd. The fraction at 800-900 Kd
inhibited colony formation at high concentrations and
enhanced colony formation on dilution. whereas the two
other active fractions contained enhancing activity at all
concentrations tested. These results would indicate that
normal serum can play a greater role in colony-forming
assays than nutritional supplements. The relationship of
the SEA factors to other factors that have been reported to
modulate bone marrow colony formation is discussed.
C 1989 by Grune & Stratton, Inc.
ment of Tumor Biology, Karolinska Institute; and Department of
Immunology, Karolinska Institute.
CFU-C assay. Bone marrow cells were obtained from mice by
aspiration of the femurs and tibias. Cells were washed twice in
RPMI 1640 (Gibco) before counting. Bone marrow cells (105/mL)
were seeded in 1 mL of 0.3% agarose (Sea Plaque, FMC Corp.
Rockland, ME) containing an exogenous source of CSF in 30 mm
gridded culture dishes. RPMI 1640 supplemented with antibiotics,
L-glutamine (2 mM), sodium pyruvate (1 mM) (Gibco, Middlesex,
England), B2-mercaptoethanob (5 x i0￿ M) and 20% heat-
inactivated fetal bovine serum (FBS) (Gibco) was used in the
agarose cultures. IL-3 was obtained (as indicated in the results) from
media conditioned by the murine myebomonocytic leukemic WEHI-
3 (a gift from Dr Norman Iscove), or from 48-hour supernatants of
Con A-stimulated rat spleen cells. Alpha methyl mannoside was
included in the cultures to preclude any effects that Con A remain-
ing in the rat spleen cell supernatants might have on colony
formation. The levels of alpha methyl mannoside added were
sufficient to eliminate any residual Con A mitogenic activity as
assayed on responsive lymphocyte populations. Alpha methyl man-
noside alone had no effect on colony formation. In assays for
inhibition of bone marrow colony formation, test supernatants were
either (as indicated in results) added directly to the bone marrow
agarose cultures or bone marrow cells were incubated in the test
supernatants for the indicated time, washed, and then resuspended
in agarose containing IL-3. When NMS was added after the
initiation of the colony-forming assay, the bone marrow cells were
originally plated in 0.35% agarose. An overlay of 0.3% agarose
containing the appropriate concentrations of NMS, FBS, and IL-3
to give the indicated final concentrations was added at the appropri-
ate day. Control plates were given overlays containing comparable
quantities of FBS and IL-3, without the addition of NMS. Colonies
of greater than 50 cells were scored after seven days of incubation at
37#{176}C in 5% CO2. All samples were run in duplicate.
Serum. Serum was obtained by retro-orbitab bleeding. After
clotting, the serum was cleared by centrifugation and used immedi-
ately for assay.
Columnfractionation ofserum. The chromatography was done
according to the Pharmacia Fine Chemicals Inc instruction manual
(Uppsala, Sweden). Fractionation was ￿ performed at 4#{176}C with
Sepharose CL-6b equilibrated with 0.9% NaCl and 10 mM HEPES.
Column size was 95.5 x 1.5 cm, with sample volume being 2.5mL of
NMS. The flow rate was 0.24 mL/minute, with a void volume (as
determined from the elution volume of blue dextran 2000) of 63 mL.
The eluate was collected in fractions, sterile filtered, and tested for
SEA activity.
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RESULTS
Serum enhancement of bone marrow colony forma-
tion. Mouse bone marrow cells were cultured in agarose
cultures containing optimal concentrations of both fetal calf
serum and WEHI-3 conditioned medium (a potent source of
IL-3).”2 When normal mouse serum or plasma having no
detectable colony-stimulating activity (data not shown) was
included in the cultures, colony counts following seven days
of culture were increased greatly (Table 1), as was the size of
the individual colonies. Serum concentrations as low as 0.6%
were found to increase colony counts significantly (data not
shown). Serum concentrations that were found to enhance
colony formation (groups of greater than 50 cells) were also
found to enhance cluster number (groups of 5-50 cells). The
serum-enhancing activity on bone marrow colony formation
was not restricted to cultures using WEHI-3-conditioned
medium-derived CSF but also was apparent in cultures
stimulated with CSFs obtained in supernatants from Con
A-stimulated rat spleen cells (data not shown).
Addition of NMS directly to IL-3-containing bone mar-
row cultures resulted in a significant increase in colony
formation. Preincubation of bone marrow cells with NMS
alone, followed by culture in IL-3 containing agarose did not
result in substantial increases in colony number (Table 1).
Addition of NMS after initiation of bone marrow cultures
resulted in large increases in final colony number (Fig 1),
with small increases in colony number resulting from the
addition of NMS as late as six days into the seven-day
culture period in some experiments.
Effects of age, strain, and species on production of
SEA. SEA did not appear to be related to the age of the
mouse from which the serum was obtained. Serum samples
obtained from C57B1/6 (B6) mice varying from 5 to 31
weeks of age were all found to stimulate roughly similar
levels of colony number enhancement when bone marrow
was from the same strain (Table 2).
Experiments were done testing the ability of sera derived
from a variety of strains to enhance the colony formation of
(B6 X DBA/2)F1 (BDF1) or B6 bone marrow. These results
Table 1 . Effects of Preincubation in NMS on Colony Formation
Colmrns Obtained with Tr.atment
Strain of Sera Du.ctt
Serum Donor Concen￿ation Addition Pr.IncL￿atIOn￿
- 0% 71.0±2.0 73.0±7.0
B6 2% 225.0 ± 8.0 83.5 ± 6.5
B6 5% 227.5 ± 16.5 90.5 ± 7.5
B6 10% 254.0 ± 8.0 85.5 ± 7.5
BDF, 2% 91.0 ± 8.0 73.5 ± 2.5
BDF, 5% 232.5 ± 10.5 65.5 ± 5.5
BDF, 10% 257￿ 94.0 ± 4.0
#{149}Colonies p& 10￿ bone marrow cells.
tIn this experiment, B6 bone marrow cells were mixed directly with
indicated concentrations of NMS and 25% WEHI 3 conditioned superna-
tants and culti.wed as described in agarose for seven days.
￿In this experiment, B6 bone marrow cells were mixed with the
indicated concentrations of NMS for seven hours before culture in
ageroso containin9 WEHI 3 conditioned supernatant (preincubation).
§One replicate.
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Fig 1 . B6 bone marrow cells were plated in 0.35% agarose
cultures containing WEHI-3 conditioned media at day 0. At dayO or
the indicated day following initiation of culture. cultures were
overlaid with 1 mL ofO.3% agarose (A) or 0.3% agarose containing
NMS. such that the final culture concentration was 5% (0).
Colonies of greater than 50 cells were counted following seven
days of incubation. Colony counts are indicated as colonies per 10’
cells. For further Information, see Materials and Methods. Similar
results were obtained in two additional experiments of identical
design.
are shown in Fig 2. While no dramatic separation of high and
bow enhancers is apparent, when tested on B6 bone marrow,
individual strains do appear to fall either in an upper or lower
range of enhancement. On this basis, two groupings can be
distinguished: the BDF1, DBA, A/Sn, and MRL/lpr sera all
tend to have moderate to high levels of SEA, whereas the
BALB/c, AKR, A/JAX, CBA/H, and C3H sera all tend to
have moderate to low bevels ofSEA. B6 sara does not fall into
any consistent placement. When tested on BDF1 bone mar-
row, most of the strains remain in the same categories as
tested above; however, the BDF1, AKR, and A/JAX sera all
switch categories to become low and high enhancers respec-
tively.
Data from experiments done testing the effects of BDF1 or
B6 sera on colony formation by bone marrow from various
strains obtained similar results (data not shown). Once
again, there was no dramatic separation of high and low
responders. However, as with the above experiments, individ-
Table 2. Relationship of Donor Age to SEA Level
Don￿Ags’ NMSCOnCSnSFSIIOnt
5% 1.25%
5 60.0 ± 3.5 43.5 ± 2.5
15 49.0 ± 3.0 42.5 ± 2.5
21 49.0 ± 4.0 38.5 ± 1.5
27 41.0 ± 6.0 47.5 ± 0.5
31 47.5 ± 5.5 44.0 ± 0.0
Age of B6 serum donor in weeks.
tme indicated NMS concentrations were mixed with B6 bone marrow
cells and 25% WEHI 3 conditioned me￿um. Colony counts are given as
colonies per 10’ bone marrow cells. Cuftures containing 25% WEHI 3
supernatants in the absence of NMS contained 30 +1- 0.5 colonies
and cultures with media alone, 0 colonies. For further information, see
Materials and Methods.
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Fig 2. Bone marrow cells
from either BDF, (experiment A)
or B6 (experiments B. C. and D)
animals were plated in cultures
containing WEHI-3 conditioned
media and 5% NMS from the
indicated strain. Colonies of
greater than 50 cells were
counted following seven days of
incubation. Colony counts are
indicated as colonies per 10’
cells.
ments in giving relatively high or lower responses within the
group of strains compared.
Human, guinea pig, and rat sera were also assayed for
their ability to enhance mouse bone marrow colony forma-
tion. While Lewis rat serum appeared to have low levels of
SEA for B6 bone marrow colony formation, guinea pig was
somewhat inhibitory, and various preparations of human
sera when added to the in vitro colony-forming assay resulted
in greatly reduced numbers of colonies relative to controls
(data not shown). Reciprocally, when normal BDF1 sera
containing potent mouse bone marrow colony-enhancing
activity was added to human bone marrow cultures (stimu-
lated by either CSF containing placenta-conditioned media
or GCT-conditioned media [Gibco]), no enhancing activity
was seen, and in some cases colony numbers were slightly
reduced (data not shown).
Production of SEA is resistant to long-term irradia-
tion. The effects of long-term irradiation of bone marrow
cells on the levels of colony-enhancing activity and potential
radiosensitivity of the producing cells were examined. In one
series of experiments (shown in Fig 3), mice were given
0.4-0.8 Ci of 89Sr. Sera were collected two to three months
later and assayed for colony-enhancing activity. Levels of
colony-enhancing activity in the sera from 89Sr-irradiated
animals were found to be similar to the levels in the control
C,)
z
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Fig 3. Bone marrow cells from CBA/H mice were cultured in
the presence of 5% NMS from normal CBA/H animals (column A)
or from animals that had been given 0.4-0.8 ￿sCi of “Sr two to
three months earlier (columns B-F). Colonies of greater than 50
cells were counted following seven days of incubation.
animals. In contrast, the levels of natural killer (NK) cell
activity was greatly reduced in these animals (data not
shown), as is normally found in animals treated with 89Sr.’5
Characterization of SEA. Whole sera containing SEA
were tested for heat lability. SEA was found to be stable at
temperatures up to 90#{176}C following one hour of treatment
(data not shown).
Serum fractionation studies using Sepharose CL-6B col-
umns demonstrated three active fractions with molecular
weights (MW) of 800-900 Kd, 60-70 Kd, and 20-30 Kd (see
Fig 4). While the active fractions from 60-70 Kd and 20-30
Kd consistently enhanced bone marrow colony formation,
the active material in the 800-900 Kd fractions varied
between batches in either enhancing or inhibiting bone
marrow colony formation. Dilution of batches of high-MW
fractions that were inhibitory showed that the inhibitory
effect was seen only at high concentrations of those fractions.
When lower concentrations of the same batches were
included in the colony-forming assay, there was a profound
enhancement of bone marrow colony formation. Active
fractions of 60-70 Kd and 20-30 Kd were never found to
inhibit colony formation.
DISCUSSION
We describe here an enhancing activity for IL-3-stimu-
lated bone marrow colony formation associated with normal
mouse serum. The sera tested were found to have no colony-
stimulating activity on their own, but could enhance bone
marrow colony formation stimulated by WEHI-3-condi-
tioned media (even when saturating levels of various prepa-
rations of IL-3 and fetal bovine serum were used). No
enhancing activity was detected when bone marrow cells
were preincubated in serum and then assayed in the presence
of IL-3; however, increased numbers of colonies were seen
when the serum was added directly to the assay containing
IL-3, even if the addition was multiple days into the seven-
day assay. This would seem to suggest that either the
presence of NMS is required for a longer period of time
(such as the seven-day culture period) or that the effect of
the NMS occurs only in the presence of the IL-3.
Additionally, we found that SEA can be derived from all
strains tested so far, as well as from mice of various ages. The
results in Fig 2 indicate that the major histocompatability
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Fig 4. Bone marrow cells from BDF1 mice were cultured in the presence of a constant amount of both IL-3 (25% WEHI-3 conditioned
media) and the indicated NMS fraction number (25%). Colonies of greater than 50 cells were counted following seven days of incubation.
Positive control of 25% WEHI-3 conditioned media ( . . . ) gave 138 colonies per 10’ cells. Relative O.D. (- - -). and colonies per 10’ bone
marrow cells (-) are given. Arrows indicate. from left to right. void volume and elution volumes for 1gM. lgG, and albumin. In this
fractionation. fraction 1 9 contains the 800-900 Kd enhancing/inhibitory peak. fraction 34 contains the 60-70 Kd enhancing peak. and
fraction 46 contains the 20-30 Kd enhancing peak. Similar results were obtained in six additional fractionations. For further details. see
Materials and Methods.
complex (MHC) compatability of the sera and bone marrow
donors are unrelated to SEA levels. Although the cell source
of the activity has not yet been identified, our data suggest
that either the producer cell is a bone marrow-dependent
radiation-resistant cell, such as the radio-resistant stromal
cells,’6 or resides elsewhere in the body.
Serum fractionation studies have indicated at least three
components that can alter levels of bone marrow colony
formation, with MW of 800-900 Kd, 60-70 Kd, and 20-30
Kd. While only the two lower MW active fractions have been
found to have enhancing activity, the highest MW active
fractions have been found to eliminate colony formation at
high concentrations while enhancing colony formation at low
concentrations.
There is much confusion in the literature to date as to
whether inclusion of serum in in vitro assays of granulopoie-
sis inhibits,17’9 enhances,8’9’20’2’ or has no effect22’23 on bone
marrow colony formation. While we consistently found
enhancement of colony formation with whole serum, it was
clear from fractionation studies that at least one of the active
serum components could also inhibit at high concentrations.
It is possible therefore to speculate that the conflicting
previous reports may represent differences between the van-
ous samples in terms of the amounts of the three active
components we have identified. Whether such changes in
composition can occur due to differences in environmental
conditions, endogenous pathogens, or disease has not been
shown and would provide an interesting area for further
investigation.
Primarily, serum-associated inhibitory activity has been
attributed to serum lipoproteins, although whether the inhi-
bition is due to very-light-density, light-density, or high-
density lipoproteins is still a matter of controversy)719 The
inhibitory activity described by Metcalf and RusselPt would
not seem to correspond with the high-MW inhibitor we have
described, as it has a MW of around 250 Kd and is effective
as an inhibitor even when bone marrow cells are preincu-
bated in the active fractions. The results of Mortensen et al’7
more closely resemble ours, in that preincubation in the
active fractions has no effect on subsequent colony-forming
assay; they show no evidence, however, for associated
enhancing activity upon dilution.
Enhancement of colony formation by serum has been
attributed to both hemin and hemoglobin8’9’2’ as well as to an
unidentified factor described by Metcalf et a12#{176} that elutes
from a G- 100 column in the region of serum albumin. While
it is possible that hemin and/or hemoglobin contributes in
part to the SEA described here, it is unlikely they are
responsible for a major portion of the activity in that the
enhancing effects of hemoglobin and hemin seemed to be
relatively species unrestricted. The factor described by Met-
calf et al,2#{176} in addition to being relatively species unrestricted
in its effects, is heat labile, which contrasts with our prelimi-
nary data for SEA. Therefore, although these previously
described serum components with colony-enhancing activity
may be responsible in part for the enhancing activity we see,
their activities do not correlate well with the characteristics
for whole serum enhancing activity.
In addition to the previous reports on serum effects on
colony-forming activity, a number of other factors have been
found to function as enhancers on inhibitors of bone marrow
colony formation. Inhibitors of bone marrow colony forma-
tion which have been described include interferon,5’24’25 acidic
isoferritins,6’7’26’27 and a T cell-derived lymphokine of approx-
imately 85,000 Kd.28 It is unlikely that the serum-associated
factor we have identified which can inhibit colony formation
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correlates with these previously described factors, as they
have not been described at any concentration to have enhanc-
ing activity and do not fall into the same molecular weight
range. Supernatants from long-term bone marrow cultures
have been found to enhance bone marrow colony formation
even in the presence of plateau (optimal) levels of CSF.293’
This colony-promoting activity (CPA) would appear to
enhance by a different mechanism than serum, as it will
promote cluster formation in the absence of CSF, which is
not seen with serum (C. Lindqvist and C. Dahl, unpublished
observations). Additionally, Izumi et al have found that bone
marrow colony formation can be enhanced by preincubation
of bone marrow cells in CPA, but that the addition of CPA
subsequent to the initiation of culture in CSF results in no
increase in colony number above controls.
More recently, it has been found that certain combinations
of interleukins and CSFs or of multiple CSFs can have
synergistic effects on colony formation by bone marrow.’#{176}
14,33 Included in these are IL-6, GCSF, IL- 1, and accessory
activity (AA),’2”3’33’34 which have all been shown to have
synergistic effects on multi-potential hemopoietic progeni-
tons when combined with IL-3. All of these factors have sizes
near or within the range of the lowest MW fraction we have
identified of around 20-30 Kd. GCSF and IL-6 are able to
stimulate colony formation in the absence of other CSFs,
while AA and IL- 1 cannot maintain colony formation. As we
have been unable to detect any colony-sustaining factors in
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described here appear to be novel. The means by which the
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